The Oncology Institute, Inc. (TOI)
The Oncology Institute, Inc. operates in the Medical - Care Facilities industry of the Healthcare sector, headquartered in Cerritos, CA, US. The stock last traded at $5.13, down 19.72% on the session, giving a market capitalisation of $512.9M. On trailing twelve-month figures it carries a trailing P/E of -18.32, a net margin of -6.2%. Its beta of 0.42 implies it has historically moved less than the broad market.
The Oncology Institute (TOI) is a specialized healthcare provider delivering a full range of medical oncology services throughout the United States. Its comprehensive offerings include direct physician care, integrated on-site infusion and medication dispensing facilities, and advanced clinical trial management. The institute also provides radiation therapy, specialized outpatient programs for stem cell transplants and transfusions, and robust patient support services. Furthermore, TOI is actively involved in operating palliative care initiatives and overseeing clinical trials. These services are specifically designed to meet the needs of adult and senior cancer patients. The company maintains a significant operational footprint with 67 clinic locations. The Oncology Institute was established in 2007 and is headquartered in Cerritos, California.
The Oncology Institute, Inc. is most often compared with the following Healthcare names: